Company: INDP
Filing Date: 2025-06-23
Form Type: DEF 14A
Source: 0001641172-25-016071
Chunk: 2

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-06-23
Form: DEF 14A
Chunk 2
---
APTUS THERAPEUTICS, INC.

3 Columbus Circle

New York, NY 10019

NOTICE OF SPECIAL MEETING OF STOCKHOLDERS

TO BE HELD friday, JULY 25, 2025</div>

The Special Meeting of Stockholders (the “Special
Meeting”) of Indaptus Therapeutics, Inc., a Delaware corporation (the “Company”), will be held at 10.00 a.m. Eastern
time on July 25, 2025, at the offices of Indaptus Therapeutics, Inc., 3 Columbus Circle, 15th Floor, New York, NY. The Special Meeting
will be held for the following purposes:

| ● | To approve, in accordance with Nasdaq Listing Rule 5635(d), the                                                                    
 issuance of (i) shares of the Company’s common stock issuable upon the conversion of convertible notes (“Notes”)                   
 issued or issuable in an ongoing private placement under Rule 506(c) of the Securities Act of 1933, as amended (the “Private       
 Placement”), and (ii) shares of common stock issuable upon exercise of certain warrants including common warrants (“Common         
 Warrants”), pre-funded warrants issuable in lieu of shares of common stock issuable upon conversion of the Notes, and placement    
 agent warrants, each of which is issuable in the Private Placement (the “Issuance Proposal”);                                      |
| ● | To approve, in accordance with Nasdaq Listing Rule 5635(c), the issuance                                                           
 of (i) shares of common stock issuable upon the conversion of one or more Notes issued or issuable in the Private Placement to the 
 Chief Executive Officer and Director of the Company (“Related Party”), and (ii) shares of common stock issuable upon               
 exercise of one or more Common Warrants issuable in the Private Placement to the Related Party (the “Related Party Proposal”);     
 and                                                                                                                                |
| ● | To transact such other business as may properly come                                                                               
 before the Special Meeting or any continuation, postponement, or adjournment of the Special Meeting.                               |

Holders of record of our common stock as of the
close of business on June 16, 2025 are entitled to notice of and to vote at the Special Meeting, or any continuation, postponement or
adjournment of the Special Meeting. A complete list of such stockholders will be open to the examination of any stockholder, for any
purpose germane